Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-11

Clinical Trial Update: Intensive Lifestyle Intervention for Type 2 Diabetics: The KP TLC Pilot [NA]

View source ↗

Summary

The KP TLC Pilot trial studying intensive lifestyle intervention for Type 2 Diabetes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kaiser Permanente | Conditions: Type 2 Diabetes | NA | Status: WITHDRAWN